Pfizer Chief Executive Officer Albert Bourla sold $5.56 million worth of company shares on Monday, the day the drugmaker said its COVID-19 vaccine was 90% effective based on interim trial results, a regulatory filing showed. France 24’s Stephen Carroll explains.
Pfizer CEO windfall: Drug Company boss earns 5.6 millions from share sale
